Pro Share Advisors LLC Prometheus Biosciences, Inc. Transaction History

Pro Share Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$103.46 - $126.29 $57,420 - $70,090	-555 Reduced 6.98%	7,391 $793,000
Q4 2022 Feb 02, 2023	BUY	$36.06 - $117.21 $40,819 - $132,681	1,132 Added 16.61%	7,946 $874,000
Q3 2022 Nov 04, 2022	BUY	$28.17 - $59.01 $191,950 - $402,094	6,814 New	6,814 $402,000
Q2 2022 Aug 01, 2022	SELL	$22.39 - $38.94 $216,063 - $375,771	-9,650 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$30.13 - $50.0 $69,841 - $115,900	-2,318 Reduced 19.37%	9,650 $365,000
Q4 2021 Feb 08, 2022	BUY	$22.28 - $39.54 $266,647 - $473,214	11,968 New	11,968 $474,000

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.